Bladder cancer after managing upper urinary tract transitional cell carcinoma: Predictive factors and pathology

Jay D. Raman, Casey K. Ng, Stephen A. Boorjian, E. Darracott Vaughan, R. Ernest Sosa, Douglas S. Scherr

Research output: Contribution to journalReview article

87 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate patients with a history of transitional cell carcinoma (TCC) of the upper urinary tract (UUT) to determine the incidence, pathological distribution, and risk factors for developing subsequent bladder tumours. PATIENTS AND METHODS: Between 1993 and 2003, 103 patients were treated at our institution for UUT-TCC. We reviewed demographic, clinical, surgical, and pathological data from these patients at a median follow-up of 38.7 months, and used univariate and multivariate analyses with logistic regression modelling to determine prognostic variables for bladder recurrences. RESULTS: In all, 51 (49.55%) patients developed bladder tumours after treatment for UUT-TCC, at a mean interval of 13.2 months. Patient age (P = 0.01), UUT tumour size (P = 0.03), UUT tumour multifocality (P = 0.05), a history of bladder tumours (P = 0.03), and the number of previous bladder tumours (P = 0.05) predicted the development of bladder recurrences on univariate analysis. On multivariate analysis, only a previous history of bladder tumours (odds ratio 2.6, P = 0.05) remained significant. Over 90% of the recurrent bladder tumours were superficial, with two-thirds of these being low to moderate grade. Six patients had muscle-invasive disease, and five had a cystectomy. CONCLUSION: Bladder tumours occurred in half the patients after treatment for UUT-TCC; >60% of these subsequent bladder tumours were superficial, low- to moderate-grade lesions. Neither the pathology of the UUT tumours nor the method of treatment for the UUT disease was associated with recurrent bladder tumours. Only a history of bladder cancer predicted the development of subsequent bladder tumours.

Original languageEnglish (US)
Pages (from-to)1031-1035
Number of pages5
JournalBJU International
Volume96
Issue number7
DOIs
StatePublished - Nov 1 2005

Fingerprint

Transitional Cell Carcinoma
Urinary Tract
Urinary Bladder Neoplasms
Pathology
Urinary Bladder
Multivariate Analysis
Urologic Diseases
Recurrence
Neoplasms
Cystectomy
Therapeutics
Logistic Models
Odds Ratio
Demography

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Raman, Jay D. ; Ng, Casey K. ; Boorjian, Stephen A. ; Vaughan, E. Darracott ; Sosa, R. Ernest ; Scherr, Douglas S. / Bladder cancer after managing upper urinary tract transitional cell carcinoma : Predictive factors and pathology. In: BJU International. 2005 ; Vol. 96, No. 7. pp. 1031-1035.
@article{7a0319ccfba8497094928f7ed6df25d9,
title = "Bladder cancer after managing upper urinary tract transitional cell carcinoma: Predictive factors and pathology",
abstract = "OBJECTIVE: To evaluate patients with a history of transitional cell carcinoma (TCC) of the upper urinary tract (UUT) to determine the incidence, pathological distribution, and risk factors for developing subsequent bladder tumours. PATIENTS AND METHODS: Between 1993 and 2003, 103 patients were treated at our institution for UUT-TCC. We reviewed demographic, clinical, surgical, and pathological data from these patients at a median follow-up of 38.7 months, and used univariate and multivariate analyses with logistic regression modelling to determine prognostic variables for bladder recurrences. RESULTS: In all, 51 (49.55{\%}) patients developed bladder tumours after treatment for UUT-TCC, at a mean interval of 13.2 months. Patient age (P = 0.01), UUT tumour size (P = 0.03), UUT tumour multifocality (P = 0.05), a history of bladder tumours (P = 0.03), and the number of previous bladder tumours (P = 0.05) predicted the development of bladder recurrences on univariate analysis. On multivariate analysis, only a previous history of bladder tumours (odds ratio 2.6, P = 0.05) remained significant. Over 90{\%} of the recurrent bladder tumours were superficial, with two-thirds of these being low to moderate grade. Six patients had muscle-invasive disease, and five had a cystectomy. CONCLUSION: Bladder tumours occurred in half the patients after treatment for UUT-TCC; >60{\%} of these subsequent bladder tumours were superficial, low- to moderate-grade lesions. Neither the pathology of the UUT tumours nor the method of treatment for the UUT disease was associated with recurrent bladder tumours. Only a history of bladder cancer predicted the development of subsequent bladder tumours.",
author = "Raman, {Jay D.} and Ng, {Casey K.} and Boorjian, {Stephen A.} and Vaughan, {E. Darracott} and Sosa, {R. Ernest} and Scherr, {Douglas S.}",
year = "2005",
month = "11",
day = "1",
doi = "10.1111/j.1464-410X.2005.05804.x",
language = "English (US)",
volume = "96",
pages = "1031--1035",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "7",

}

Bladder cancer after managing upper urinary tract transitional cell carcinoma : Predictive factors and pathology. / Raman, Jay D.; Ng, Casey K.; Boorjian, Stephen A.; Vaughan, E. Darracott; Sosa, R. Ernest; Scherr, Douglas S.

In: BJU International, Vol. 96, No. 7, 01.11.2005, p. 1031-1035.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Bladder cancer after managing upper urinary tract transitional cell carcinoma

T2 - Predictive factors and pathology

AU - Raman, Jay D.

AU - Ng, Casey K.

AU - Boorjian, Stephen A.

AU - Vaughan, E. Darracott

AU - Sosa, R. Ernest

AU - Scherr, Douglas S.

PY - 2005/11/1

Y1 - 2005/11/1

N2 - OBJECTIVE: To evaluate patients with a history of transitional cell carcinoma (TCC) of the upper urinary tract (UUT) to determine the incidence, pathological distribution, and risk factors for developing subsequent bladder tumours. PATIENTS AND METHODS: Between 1993 and 2003, 103 patients were treated at our institution for UUT-TCC. We reviewed demographic, clinical, surgical, and pathological data from these patients at a median follow-up of 38.7 months, and used univariate and multivariate analyses with logistic regression modelling to determine prognostic variables for bladder recurrences. RESULTS: In all, 51 (49.55%) patients developed bladder tumours after treatment for UUT-TCC, at a mean interval of 13.2 months. Patient age (P = 0.01), UUT tumour size (P = 0.03), UUT tumour multifocality (P = 0.05), a history of bladder tumours (P = 0.03), and the number of previous bladder tumours (P = 0.05) predicted the development of bladder recurrences on univariate analysis. On multivariate analysis, only a previous history of bladder tumours (odds ratio 2.6, P = 0.05) remained significant. Over 90% of the recurrent bladder tumours were superficial, with two-thirds of these being low to moderate grade. Six patients had muscle-invasive disease, and five had a cystectomy. CONCLUSION: Bladder tumours occurred in half the patients after treatment for UUT-TCC; >60% of these subsequent bladder tumours were superficial, low- to moderate-grade lesions. Neither the pathology of the UUT tumours nor the method of treatment for the UUT disease was associated with recurrent bladder tumours. Only a history of bladder cancer predicted the development of subsequent bladder tumours.

AB - OBJECTIVE: To evaluate patients with a history of transitional cell carcinoma (TCC) of the upper urinary tract (UUT) to determine the incidence, pathological distribution, and risk factors for developing subsequent bladder tumours. PATIENTS AND METHODS: Between 1993 and 2003, 103 patients were treated at our institution for UUT-TCC. We reviewed demographic, clinical, surgical, and pathological data from these patients at a median follow-up of 38.7 months, and used univariate and multivariate analyses with logistic regression modelling to determine prognostic variables for bladder recurrences. RESULTS: In all, 51 (49.55%) patients developed bladder tumours after treatment for UUT-TCC, at a mean interval of 13.2 months. Patient age (P = 0.01), UUT tumour size (P = 0.03), UUT tumour multifocality (P = 0.05), a history of bladder tumours (P = 0.03), and the number of previous bladder tumours (P = 0.05) predicted the development of bladder recurrences on univariate analysis. On multivariate analysis, only a previous history of bladder tumours (odds ratio 2.6, P = 0.05) remained significant. Over 90% of the recurrent bladder tumours were superficial, with two-thirds of these being low to moderate grade. Six patients had muscle-invasive disease, and five had a cystectomy. CONCLUSION: Bladder tumours occurred in half the patients after treatment for UUT-TCC; >60% of these subsequent bladder tumours were superficial, low- to moderate-grade lesions. Neither the pathology of the UUT tumours nor the method of treatment for the UUT disease was associated with recurrent bladder tumours. Only a history of bladder cancer predicted the development of subsequent bladder tumours.

UR - http://www.scopus.com/inward/record.url?scp=27444442638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27444442638&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2005.05804.x

DO - 10.1111/j.1464-410X.2005.05804.x

M3 - Review article

C2 - 16225523

AN - SCOPUS:27444442638

VL - 96

SP - 1031

EP - 1035

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 7

ER -